Bertelsmann-backed paywall management software provider Zephr is set to be acquired by Zuora in a $44m deal while Meituan co-led a $875m round for EV battery producer Sunwoda.

Public markets Third Harmonic Bio, the US-based allergy and inflammatory therapy developer backed by pharmaceutical firm Novartis, has filed to list on the Nasdaq Global Market. The company had closed a $105m series B round in December 2021 and still had $113m cash on hand as of June this year, according to the securities filing.…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.